PP
GBIO

PDT Partners’s Generation Bio GBIO Stock Holding History

PDT Partners’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,978
Closed -$75K – 584
2023
Q3 		$75K Sell
1,978
-241
-11% -$11.4K 0.01% 561
2023
Q2 		$122K Sell
2,219
-848
-28% -$38.9K 0.02% 525
2023
Q1 		$132K Buy
3,067
+1,611
+111% +$77.9K 0.02% 524
2022
Q4 		$57.2K Sell
1,456
-2,605
-64% -$137K 0.01% 600
2022
Q3 		$216K Sell
4,061
-1,755
-30% -$110K 0.03% 692
2022
Q2 		$382K Sell
5,816
-3,746
-39% -$245K 0.03% 677
2022
Q1 		$702K Buy
9,562
+5,878
+160% +$341K 0.06% 485
2021
Q4 		$261K Buy
+3,684
New +$643K 0.02% 713
2021
Q3 		– Sell
-1,264
Closed -$340K – 817
2021
Q2 		$340K Buy
+1,264
New +$378K 0.02% 600

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

PDT Partners's GBIO Position: Q4 2023 in Review

PDT Partners sold out of Generation Bio (GBIO) in Q4 2023, closing a stake of 1,978 shares — an estimated $75K sold.

PDT Partners first reported a position in GBIO in Q2 2021 and held it in 9 quarters. The position peaked at $702K in Q1 2022. 74 funds tracked by Wall St. Rank hold GBIO as of Q4 2023.

  • PDT Partners reported no remaining Generation Bio position as of Q4 2023 after selling out during the quarter.
  • PDT Partners sold 1,978 Generation Bio shares in Q4 2023, an estimated $75K.
  • PDT Partners first reported a position in Generation Bio in Q2 2021 and held it in 9 quarters.
  • PDT Partners's Generation Bio position peaked at $702K in Q1 2022.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q4 2023.

Based on PDT Partners's 13F filing for Q4 2023, filed 14 Feb 2024.